STRM.BIO (Seed)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$9,500,000

Company Info
Founders
Jonathan Thon
Company Description
A pre-clinical biotech company aiming to fulfill the promise of gene therapy by leveraging extracellular vesicles (EVs) to deliver treatment directly to the patient (in vivo). STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.
Market
Healthcare & Wellness
Coinvestors
Breakout Ventures,Delos Capital Fund II, LP,Boehringer Ingelheim Venture Fund USA, Inc,Ascension Ventures

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement